- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 221/28 - Morphinans
Patent holdings for IPC class C07D 221/28
Total number of patents in this class: 170
10-year publication summary
|
9
|
13
|
9
|
14
|
12
|
7
|
3
|
11
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 254 |
21 |
| SpecGx LLC | 186 |
16 |
| Zevra Therapeutics, Inc. | 99 |
12 |
| Sun Pharmaceutical Industries Inc | 232 |
11 |
| Mallinckrodt LLC | 131 |
8 |
| Rensselaer Polytechnic Institute | 851 |
8 |
| Concert Pharmaceuticals, Inc. | 244 |
7 |
| Avanir Pharmaceuticals, Inc. | 24 |
6 |
| Alkermes, Inc. | 137 |
5 |
| Heinrich-heine-universitat Dusseldorf | 76 |
5 |
| Kappa-Pharma LLC | 4 |
4 |
| Mallinckrodt Inc. | 135 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1505 |
3 |
| Sichuan University | 628 |
3 |
| Board of Regents, The University of Texas System | 6127 |
2 |
| Green Cross Corporation | 220 |
2 |
| KemPharm, Inc. | 27 |
2 |
| Nektar Therapeutics | 402 |
2 |
| Phoenix Pharmalabs, Inc. | 6 |
2 |
| Purdue Pharma L.P. | 448 |
2 |
| Other owners | 46 |